Literature DB >> 27072268

Modulatory effect of Pleurotus ostreatus on oxidant/antioxidant status in 7, 12-dimethylbenz (a) anthracene induced mammary carcinoma in experimental rats--A dose-response study.

Deepalakshmi Krishnamoorthy, Mirunalini Sankaran1.   

Abstract

BACKGROUND: Worldwide, breast cancer is the second most prevalent cancer among women and its incidence is increasing alarmingly. AIM: To determine a dose-response effect of Pleurotus ostreatus on oxidant/antioxidant status in 7,12-dimethylbenz. (a) antheracene induced. (DMBA) mammary carcinoma in experimental rats.
MATERIALS AND METHODS: Cancer bearing female Sprague Dawley rats were orally treated with Pleurotus ostreatus ethanolic extract (POEet) (150, 300 and 600 mg/kg body weight) for 16 weeks. By means of high performance liquid chromatography (HPLC) analysis, ergosterol (48.82%) were identified and quantified in POEet. Body weight of experimental rats in each groups and the biochemical parameters of plasma, liver and mammary tissues were carried out. Histopathological analyses were also determined. STATISTICAL ANALYSIS USED: Results were analyzed using SPSS software package, version 16.0. The values were analyzed by one way analysis of variance (ANOVA) followed by Duncan's multiple range test (DMRT). RESULT: The result showed that depleted activities of enzymatic and non-enzymatic antioxidant level and significant elevated TBARS level were observed in DMBA group of plasma, mammary and liver tissues of experimental rats. The effects were dose.dependent and the above noted parameters were renovated to near normal after supplementation with different dose of POEet (150 mg, 300 mg and 600 mg/kg bwt). The data obtained from the study indicate that POEet at a dose of 600 mg/kg bwt possesses optimum anticancer effects against DMBA induced mammary carcinogenesis.
CONCLUSION: Based on the scientific appraisal, we conclude that the POEet is having a potent antioxidant capacity; thereby it offers maximum protection against DMBA-induced mammary carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27072268     DOI: 10.4103/0973-1482.148691

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  6 in total

1.  Anti-cancer effect of in vivo inhibition of nitric oxide synthase in a rat model of breast cancer.

Authors:  Nikolay Avtandilyan; Hayarpi Javrushyan; Mikayel Ginovyan; Anna Karapetyan; Armen Trchounian
Journal:  Mol Cell Biochem       Date:  2022-08-13       Impact factor: 3.842

Review 2.  Effects of bioactive compounds from Pleurotus mushrooms on COVID-19 risk factors associated with the cardiovascular system.

Authors:  Eduardo Echer Dos Reis; Paulo Cavalheiro Schenkel; Marli Camassola
Journal:  J Integr Med       Date:  2022-07-11

3.  Investigation of the Anticancer Effect of α-Aminophosphonates and Arylidine Derivatives of 3-Acetyl-1-aminoquinolin-2(1H)-one on the DMBA Model of Breast Cancer in Albino Rats with In Silico Prediction of Their Thymidylate Synthase Inhibitory Effect.

Authors:  Mohamed A Nassan; Adil Aldhahrani; Hamada H Amer; Ahmed Elhenawy; Ayman A Swelum; Omar M Ali; Yasser H Zaki
Journal:  Molecules       Date:  2022-01-24       Impact factor: 4.411

Review 4.  Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics.

Authors:  Tongmeng Jiang; Tao Yang; Yingfan Chen; Yao Miao; Yajing Xu; Honglin Jiang; Mingying Yang; Chuanbin Mao
Journal:  Theranostics       Date:  2022-03-14       Impact factor: 11.600

5.  Lion's Mane Mushroom, Hericium erinaceus (Bull.: Fr.) Pers. Suppresses H2O2-Induced Oxidative Damage and LPS-Induced Inflammation in HT22 Hippocampal Neurons and BV2 Microglia.

Authors:  Naufal Kushairi; Chia Wei Phan; Vikineswary Sabaratnam; Pamela David; Murali Naidu
Journal:  Antioxidants (Basel)       Date:  2019-08-01

6.  Therapeutic effect of Aegle marmelos fruit extract against DMBA induced breast cancer in rats.

Authors:  Vivek Akhouri; Manorma Kumari; Arun Kumar
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.